URGNNasdaq Israel
Market cap
$2.295 B
$46.96 +2.98%
Close of 7 Aug 2026
Revenue
$109.8M
#2485 by revenue
Earnings
-$153.5M
Loss-making
Shares outstanding
48,880,564
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for UroGen Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.